Cargando…

Income in Multiple Sclerosis Patients with Different Disease Phenotypes

BACKGROUND: Multiple sclerosis (MS) is a disease with profound heterogeneity in clinical course. OBJECTIVE: To analyze sources and levels of income among MS patients in relation to disease phenotype with a special focus on identifying differences/similarities between primary progressive MS (PPMS) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kavaliunas, Andrius, Manouchehrinia, Ali, Danylaite Karrenbauer, Virginija, Gyllensten, Hanna, Glaser, Anna, Alexanderson, Kristina, Hillert, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5231357/ https://www.ncbi.nlm.nih.gov/pubmed/28081163 http://dx.doi.org/10.1371/journal.pone.0169460

Ejemplares similares

Importance of early treatment decisions on future income of multiple sclerosis patients
por: Kavaliunas, Andrius, et al.
Publicado: (2020)

Systematic Review of the Socioeconomic Consequences in Patients With Multiple Sclerosis With Different Levels of Disability and Cognitive Function
por: Kavaliunas, Andrius, et al.
Publicado: (2022)

Cognitive function predicts work disability among multiple sclerosis patients
por: Kavaliunas, Andrius, et al.
Publicado: (2019)

Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study
por: Karrenbauer, Virginija Danylaité, et al.
Publicado: (2021)

Costs of illness progression for different multiple sclerosis phenotypes: a population-based study in Sweden
por: Gyllensten, Hanna, et al.
Publicado: (2019)

Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients
por: Kavaliunas, Andrius, et al.
Publicado: (2015)

Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden
por: Karampampa, Korinna, et al.
Publicado: (2022)

Costs and quality of life by disability among people with multiple sclerosis: a register-based study in Sweden
por: Gyllensten, Hanna, et al.
Publicado: (2018)

Accurate classification of secondary progression in multiple sclerosis using a decision tree
por: Ramanujam, Ryan, et al.
Publicado: (2020)

Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
por: McKay, Kyla A., et al.
Publicado: (2021)

Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab
por: Karampampa, Korinna, et al.
Publicado: (2023)

Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age
por: Gyllensten, Hanna, et al.
Publicado: (2017)

The long-term impact of early treatment of multiple sclerosis on the risk of disability pension
por: Landfeldt, Erik, et al.
Publicado: (2018)

Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in Sweden
por: Karampampa, Korinna, et al.
Publicado: (2019)

Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context
por: He, Anna, et al.
Publicado: (2023)

Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis
por: He, Anna H, et al.
Publicado: (2023)

Long-term disability progression of pediatric-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2019)

Depression and multiple sclerosis: A bidirectional Mendelian randomisation study
por: Binzer, Stefanie, et al.
Publicado: (2021)

Cost of Illness of Multiple Sclerosis - A Systematic Review
por: Ernstsson, Olivia, et al.
Publicado: (2016)

The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case–control study
por: Boles, Graysen Steele, et al.
Publicado: (2023)

Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy
por: Han, Jinming, et al.
Publicado: (2020)

How does work disability of patients with MS develop before and after diagnosis? A nationwide cohort study with a reference group
por: Gyllensten, Hanna, et al.
Publicado: (2016)

Age Related Multiple Sclerosis Severity Score: Disability ranked by age
por: Manouchehrinia, Ali, et al.
Publicado: (2017)

Smoking Attributable Risk in Multiple Sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2022)

Association of Pre-Disease Body Mass Index With Multiple Sclerosis Prognosis
por: Manouchehrinia, Ali, et al.
Publicado: (2018)

Determinants of quality of life in pediatric- and adult-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2020)

Validation of multiple sclerosis diagnoses in the Swedish National Patient Register
por: Murley, Chantelle, et al.
Publicado: (2019)

Self‐employment, sickness absence, and disability pension in multiple sclerosis
por: Machado, Alejandra, et al.
Publicado: (2022)

A multiple sclerosis disease progression measure based on cumulative disability
por: Manouchehrinia, Ali, et al.
Publicado: (2021)

Four Swedish cases of CSF1R‐related leukoencephalopathy: Visualization of clinical phenotypes
por: Rosenstein, Igal, et al.
Publicado: (2022)

Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment
por: Bedri, Sahl Khalid, et al.
Publicado: (2019)

Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges
por: Han, Jinming, et al.
Publicado: (2022)

The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden
por: Ernstsson, Olivia, et al.
Publicado: (2017)

Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study
por: Binzer, Stefanie, et al.
Publicado: (2019)

Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study
por: He, Anna, et al.
Publicado: (2023)

Incidence rate and sex ratio in multiple sclerosis in Lithuania
por: Valadkeviciene, Daiva, et al.
Publicado: (2018)

Gender differences in earnings among people with multiple sclerosis and associations with type of occupation and family composition: A population-based study with matched references
por: Machado, Alejandra, et al.
Publicado: (2023)

Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group
por: Murley, Chantelle, et al.
Publicado: (2021)

Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse
por: McKay, Kyla A., et al.
Publicado: (2022)

Excess costs of multiple sclerosis: a register-based study in Sweden
por: Murley, Chantelle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nu0tkm3b3o7f8cl07g1bjctegs